BSX vs LFVN · P/E 20, rev $10.65B vs P/E 13, rev $182.6M
Boston Scientific Corp (BSX) versus Lifevantage Corporation (LFVN) — a side-by-side from cached financials, not a winner call.
Boston Scientific Corp (BSX) is a medical devices company listed on US.
Lifevantage Corporation (LFVN) is a packaged foods company listed on NASDAQ.
Latest reported BSX revenue for 2026-06-30 was $10.65B. Net income was $2.24B. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
Latest reported LFVN revenue for 2026-06-30 was $182.6M. Net income was $5.1M. Revenue was down 20.1% from 2025-06-30 to 2026-06-30. LFVN currently screens at market cap $76.5M and trailing P/E 13.5.
BSX currently screens at market cap $71.81B and trailing P/E 20.2. LFVN currently screens at market cap $76.5M and trailing P/E 13.5.
Not investment advice. Open the BSX and LFVN stock pages for the full models.
Not investment advice.